Robert Nelsen - Net Worth and Insider Trading

Over the past 18 months, Robert Nelsen made no insider transaction in Codiak BioSciences Inc (CDAKQ). Other recent insider transactions involving Codiak BioSciences Inc (CDAKQ) include a net sale of 61,535 shares made by Douglas E Williams , a net sale of 20,226 shares made by Linda Bain , and a net sale of 17,534 shares made by Sriram Sathyanarayanan .

In summary, during the past 3 months, insiders sold 0 shares of Codiak BioSciences Inc (CDAKQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 129,081 shares of Codiak BioSciences Inc (CDAKQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 129,081 shares.

Codiak BioSciences Inc (CDAKQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Robert Nelsen made no insider transaction in Metacrine Inc (MTCR). Other recent insider transactions involving Metacrine Inc (MTCR) include a net sale of 380,605 shares made by Preston Klassen , a net purchase of 271,605 shares made by Braden Michael Leonard , and a net sale of 107,054 shares made by Michael York .

In summary, during the past 3 months, insiders sold 0 shares of Metacrine Inc (MTCR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 487,659 shares of Metacrine Inc (MTCR) were sold and 271,605 shares were bought by its insiders, resulting in a net sale of 216,054 shares.

Metacrine Inc (MTCR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Robert Nelsen made no insider transaction in Unity Biotechnology Inc (UBX). Other recent insider transactions involving Unity Biotechnology Inc (UBX) include a net sale of 17,896 shares made by Anirvan Ghosh , and a net sale of 3,304 shares made by Jamie Dananberg .

In summary, during the past 3 months, insiders sold 603 shares of Unity Biotechnology Inc (UBX) in total and bought 0 shares, with a net sale of 603 shares. During the past 18 months, 21,200 shares of Unity Biotechnology Inc (UBX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 21,200 shares.

Unity Biotechnology Inc (UBX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Robert Nelsen made no insider transaction in Karuna Therapeutics Inc (KRTX). Other recent insider transactions involving Karuna Therapeutics Inc (KRTX) include a net sale of 80,000 shares made by Stephen K. Brannan , a net sale of 17,517 shares made by Troy A. Ignelzi , and a net sale of 41,429 shares made by Jeffrey M Jonas .

In summary, during the past 3 months, insiders sold 5,000 shares of Karuna Therapeutics Inc (KRTX) in total and bought 0 shares, with a net sale of 5,000 shares. During the past 18 months, 205,973 shares of Karuna Therapeutics Inc (KRTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 205,973 shares.

Karuna Therapeutics Inc (KRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Robert Nelsen made no insider transaction in Denali Therapeutics Inc (DNLI). Other recent insider transactions involving Denali Therapeutics Inc (DNLI) include a net sale of 106,621 shares made by Alexander O. Schuth , a net sale of 42,800 shares made by Carole Ho , and a net sale of 186,802 shares made by Ryan J. Watts .

In summary, during the past 3 months, insiders sold 95,832 shares of Denali Therapeutics Inc (DNLI) in total and bought 0 shares, with a net sale of 95,832 shares. During the past 18 months, 480,892 shares of Denali Therapeutics Inc (DNLI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 480,892 shares.

Denali Therapeutics Inc (DNLI)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Robert Nelsen made no insider transaction in Vir Biotechnology Inc (VIR). Other recent insider transactions involving Vir Biotechnology Inc (VIR) include a net sale of 4,584,416 shares made by Svf Endurance (cayman) Ltd , a net sale of 58,569 shares made by Phillip Pang , and a net sale of 89,680 shares made by Vicki L Sato .

In summary, during the past 3 months, insiders sold 136,328 shares of Vir Biotechnology Inc (VIR) in total and bought 0 shares, with a net sale of 136,328 shares. During the past 18 months, 4,958,534 shares of Vir Biotechnology Inc (VIR) were sold and 7,500 shares were bought by its insiders, resulting in a net sale of 4,951,034 shares.

Vir Biotechnology Inc (VIR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Robert Nelsen made no insider transaction in Beam Therapeutics Inc (BEAM). Other recent insider transactions involving Beam Therapeutics Inc (BEAM) include a net sale of 114,771 shares made by Terry-ann Burrell , a net sale of 17,788 shares made by Christine Bellon , and a net sale of 215,751 shares made by Giuseppe Ciaramella .

In summary, during the past 3 months, insiders sold 115,170 shares of Beam Therapeutics Inc (BEAM) in total and bought 0 shares, with a net sale of 115,170 shares. During the past 18 months, 1,383,256 shares of Beam Therapeutics Inc (BEAM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,383,256 shares.

Beam Therapeutics Inc (BEAM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Robert Nelsen made no insider transaction in Syros Pharmaceuticals Inc (SYRS). Other recent insider transactions involving Syros Pharmaceuticals Inc (SYRS) include a net sale of 30,523 shares made by David Roth , a net purchase of 904,977 shares made by Srinivas Akkaraju , and a net sale of 689 shares made by Eric R Olson .

In summary, during the past 3 months, insiders sold 10,601 shares of Syros Pharmaceuticals Inc (SYRS) in total and bought 0 shares, with a net sale of 10,601 shares. During the past 18 months, 31,212 shares of Syros Pharmaceuticals Inc (SYRS) were sold and 904,977 shares were bought by its insiders, resulting in a net purchase of 873,765 shares.

Syros Pharmaceuticals Inc (SYRS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Robert Nelsen made no insider transaction in Homology Medicines Inc (FIXX). Other recent insider transactions involving Homology Medicines Inc (FIXX) include a net sale of 21,335 shares made by Paul Alloway , a net sale of 23,653 shares made by Arthur Tzianabos , and a net sale of 5,068 shares made by Albert Seymour .

In summary, during the past 3 months, insiders sold 0 shares of Homology Medicines Inc (FIXX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,328 shares of Homology Medicines Inc (FIXX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,328 shares.

Homology Medicines Inc (FIXX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Sienna Biopharmaceuticals Inc (SNNAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sienna Biopharmaceuticals Inc (SNNAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sienna Biopharmaceuticals Inc (SNNAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Robert Nelsen made no insider transaction in Gossamer Bio Inc (GOSS). Other recent insider transactions involving Gossamer Bio Inc (GOSS) include a net purchase of 298,570 shares made by Bryan Giraudo , a net sale of 13,395 shares made by Richard Aranda , and a net purchase of 855,400 shares made by Faheem Hasnain .

In summary, during the past 3 months, insiders sold 44,068 shares of Gossamer Bio Inc (GOSS) in total and bought 0 shares, with a net sale of 44,068 shares. During the past 18 months, 67,038 shares of Gossamer Bio Inc (GOSS) were sold and 1,234,072 shares were bought by its insiders, resulting in a net purchase of 1,167,034 shares.

Gossamer Bio Inc (GOSS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Robert Nelsen made no insider transaction in Twist Bioscience Corp (TWST). Other recent insider transactions involving Twist Bioscience Corp (TWST) include a net purchase of 8,708 shares made by Dennis Cho , a net sale of 3,391 shares made by William Banyai , and a net sale of 7,910 shares made by Emily M. Leproust .

In summary, during the past 3 months, insiders sold 19,103 shares of Twist Bioscience Corp (TWST) in total and bought 0 shares, with a net sale of 19,103 shares. During the past 18 months, 27,952 shares of Twist Bioscience Corp (TWST) were sold and 10,000 shares were bought by its insiders, resulting in a net sale of 17,952 shares.

Twist Bioscience Corp (TWST)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Robert Nelsen made no insider transaction in Scholar Rock Holding Corp (SRRK). Other recent insider transactions involving Scholar Rock Holding Corp (SRRK) include a net sale of 83,758 shares made by Edward H Myles , a net purchase of 2,279,168 shares made by Invus Public Equities, L.p. , and a net sale of 31,121 shares made by Mo Qatanani .

In summary, during the past 3 months, insiders sold 0 shares of Scholar Rock Holding Corp (SRRK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 128,112 shares of Scholar Rock Holding Corp (SRRK) were sold and 6,659,824 shares were bought by its insiders, resulting in a net purchase of 6,531,712 shares.

Scholar Rock Holding Corp (SRRK)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Pulmatrix Inc (PULM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pulmatrix Inc (PULM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Pulmatrix Inc (PULM)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Juno Therapeutics Inc (JUNO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Juno Therapeutics Inc (JUNO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Juno Therapeutics Inc (JUNO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Robert Nelsen made no insider transaction in Quanterix Corp (QTRX). Other recent insider transactions involving Quanterix Corp (QTRX) include a net sale of 5,500 shares made by Laurie J Olson , and a net purchase of 20,200 shares made by William P Donnelly .

In summary, during the past 3 months, insiders sold 2,500 shares of Quanterix Corp (QTRX) in total and bought 0 shares, with a net sale of 2,500 shares. During the past 18 months, 5,500 shares of Quanterix Corp (QTRX) were sold and 20,200 shares were bought by its insiders, resulting in a net purchase of 14,700 shares.

Quanterix Corp (QTRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Robert Nelsen made no insider transaction in Agios Pharmaceuticals Inc (AGIO). Other recent insider transactions involving Agios Pharmaceuticals Inc (AGIO) include a net sale of 205,692 shares made by David P Schenkein , a net sale of 8,791 shares made by Washburn Theodore James Jr. , and a net sale of 14,160 shares made by James William Burns .

In summary, during the past 3 months, insiders sold 91,531 shares of Agios Pharmaceuticals Inc (AGIO) in total and bought 0 shares, with a net sale of 91,531 shares. During the past 18 months, 358,881 shares of Agios Pharmaceuticals Inc (AGIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 358,881 shares.

Agios Pharmaceuticals Inc (AGIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Xtera Communications Inc (XCOMQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Xtera Communications Inc (XCOMQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Xtera Communications Inc (XCOMQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Robert Nelsen made no insider transaction in Impinj Inc (PI). Other recent insider transactions involving Impinj Inc (PI) include a net sale of 71,016 shares made by Jeffrey Dossett , a net sale of 125,091 shares made by Diorio Chris Ph.d. , and a net sale of 70,340 shares made by Hussein Mecklai .

In summary, during the past 3 months, insiders sold 134,321 shares of Impinj Inc (PI) in total and bought 0 shares, with a net sale of 134,321 shares. During the past 18 months, 739,713 shares of Impinj Inc (PI) were sold and 1,627,591 shares were bought by its insiders, resulting in a net purchase of 887,878 shares.

Impinj Inc (PI)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of PhaseRx Inc (PZRXQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of PhaseRx Inc (PZRXQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

PhaseRx Inc (PZRXQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Robert Nelsen made no insider transaction in Sage Therapeutics Inc (SAGE). Other recent insider transactions involving Sage Therapeutics Inc (SAGE) include a net purchase of 3,000 shares made by Elizabeth Barrett , and a net sale of 11,643 shares made by Jeffrey M Jonas .

In summary, during the past 3 months, insiders sold 0 shares of Sage Therapeutics Inc (SAGE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 11,643 shares of Sage Therapeutics Inc (SAGE) were sold and 3,000 shares were bought by its insiders, resulting in a net sale of 8,643 shares.

Sage Therapeutics Inc (SAGE)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Adesto Technologies Corp (IOTS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Adesto Technologies Corp (IOTS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Adesto Technologies Corp (IOTS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Robert Nelsen made no insider transaction in Bellerophon Therapeutics Inc (BLPH). Other recent insider transactions involving Bellerophon Therapeutics Inc (BLPH) include a net sale of 694,421 shares made by Puissance Capital Fund (gp) Llc , a net sale of 1,076,841 shares made by Puissance Life Science Opportunities Fund Vi , and a net sale of 9,455 shares made by Bobae Kim .

In summary, during the past 3 months, insiders sold 0 shares of Bellerophon Therapeutics Inc (BLPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,780,717 shares of Bellerophon Therapeutics Inc (BLPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,780,717 shares.

Bellerophon Therapeutics Inc (BLPH)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Achaogen Inc (AKAOQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Achaogen Inc (AKAOQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Achaogen Inc (AKAOQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Robert Nelsen made no insider transaction in Fate Therapeutics Inc (FATE). Other recent insider transactions involving Fate Therapeutics Inc (FATE) include a net sale of 26,108 shares made by Dulac Edward J Iii , a net purchase of 44,630 shares made by Redmile Group, Llc , and a net sale of 46,790 shares made by Cindy Tahl .

In summary, during the past 3 months, insiders sold 0 shares of Fate Therapeutics Inc (FATE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 479,444 shares of Fate Therapeutics Inc (FATE) were sold and 471,648 shares were bought by its insiders, resulting in a net sale of 7,796 shares.

Fate Therapeutics Inc (FATE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Robert Nelsen made no insider transaction in bluebird bio Inc (BLUE). Other recent insider transactions involving bluebird bio Inc (BLUE) include a net sale of 32,050 shares made by Andrew Obenshain , a net sale of 12,339 shares made by Thomas J Klima , and a net sale of 10,267 shares made by Richard A Colvin .

In summary, during the past 3 months, insiders sold 17,438 shares of bluebird bio Inc (BLUE) in total and bought 0 shares, with a net sale of 17,438 shares. During the past 18 months, 68,689 shares of bluebird bio Inc (BLUE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 68,689 shares.

bluebird bio Inc (BLUE)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of NeurogesX Inc (NGSX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NeurogesX Inc (NGSX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

NeurogesX Inc (NGSX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Robert Nelsen made no insider transaction in Cyclacel Pharmaceuticals Inc (CYCC). Other recent insider transactions involving Cyclacel Pharmaceuticals Inc (CYCC) include a net purchase of 6,070 shares made by Spiro Rombotis , and a net purchase of 1,886 shares made by Paul Mcbarron .

In summary, during the past 3 months, insiders sold 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) were sold and 7,956 shares were bought by its insiders, resulting in a net purchase of 7,956 shares.

Cyclacel Pharmaceuticals Inc (CYCC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Robert Nelsen made no insider transaction in Alnylam Pharmaceuticals Inc (ALNY). Other recent insider transactions involving Alnylam Pharmaceuticals Inc (ALNY) include a net sale of 30,567 shares made by Pushkal Garg , a net sale of 7,095 shares made by Indrani Lall Franchini , and a net sale of 14,604 shares made by Yvonne Greenstreet .

In summary, during the past 3 months, insiders sold 34,910 shares of Alnylam Pharmaceuticals Inc (ALNY) in total and bought 0 shares, with a net sale of 34,910 shares. During the past 18 months, 159,676 shares of Alnylam Pharmaceuticals Inc (ALNY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 159,676 shares.

Alnylam Pharmaceuticals Inc (ALNY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Robert Nelsen made no insider transaction in Illumina Inc (ILMN). Other recent insider transactions involving Illumina Inc (ILMN) include a net sale of 8,000 shares made by Susan H Tousi , a net sale of 1,186 shares made by Aimee L Hoyt , and a net purchase of 7,330 shares made by Jacob Thaysen .

In summary, during the past 3 months, insiders sold 0 shares of Illumina Inc (ILMN) in total and bought 7,330 shares, with a net purchase of 7,330 shares. During the past 18 months, 14,584 shares of Illumina Inc (ILMN) were sold and 7,330 shares were bought by its insiders, resulting in a net sale of 7,254 shares.

Illumina Inc (ILMN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Robert Nelsen made no insider transaction in 908 Devices Inc (MASS). Other recent insider transactions involving 908 Devices Inc (MASS) include a net sale of 63,120 shares made by Kevin J. Knopp , a net sale of 49,991 shares made by Christopher D. Brown , and a net sale of 32,091 shares made by Griffith Joseph H. Iv .

In summary, during the past 3 months, insiders sold 0 shares of 908 Devices Inc (MASS) in total and bought 50,000 shares, with a net purchase of 50,000 shares. During the past 18 months, 206,454 shares of 908 Devices Inc (MASS) were sold and 52,585 shares were bought by its insiders, resulting in a net sale of 153,869 shares.

908 Devices Inc (MASS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Robert Nelsen made no insider transaction in Erasca Inc (ERAS). Other recent insider transactions involving Erasca Inc (ERAS) include a net purchase of 2,300,000 shares made by Jonathan E Lim , a net purchase of 70,000 shares made by Alexander W. Casdin , and a net purchase of 615,384 shares made by Bihua Chen .

In summary, during the past 3 months, insiders sold 0 shares of Erasca Inc (ERAS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Erasca Inc (ERAS) were sold and 3,025,384 shares were bought by its insiders, resulting in a net purchase of 3,025,384 shares.

Erasca Inc (ERAS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Robert Nelsen made 1 insider transaction in Sana Biotechnology Inc (SANA) with a net purchase of 1,818,181. Other recent insider transactions involving Sana Biotechnology Inc (SANA) include a net sale of 949,000 shares made by Flagship Ventures Fund V, L.p. , a net purchase of 1,818,181 shares made by Keith Crandell , and a net purchase of 1,818,181 shares made by Arch Venture Fund X Overage, L.p. .

In summary, during the past 3 months, insiders sold 25,000 shares of Sana Biotechnology Inc (SANA) in total and bought 0 shares, with a net sale of 25,000 shares. During the past 18 months, 1,049,000 shares of Sana Biotechnology Inc (SANA) were sold and 5,454,543 shares were bought by its insiders, resulting in a net purchase of 4,405,543 shares.

Sana Biotechnology Inc (SANA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Robert Nelsen made no insider transaction in Lyell Immunopharma Inc (LYEL). Other recent insider transactions involving Lyell Immunopharma Inc (LYEL) include a net sale of 58,020 shares made by Richard Klausner ,

In summary, during the past 3 months, insiders sold 0 shares of Lyell Immunopharma Inc (LYEL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 58,020 shares of Lyell Immunopharma Inc (LYEL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 58,020 shares.

Lyell Immunopharma Inc (LYEL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Robert Nelsen made no insider transaction in Verve Therapeutics Inc (VERV). Other recent insider transactions involving Verve Therapeutics Inc (VERV) include a net sale of 1,108 shares made by Allison Dorval , a net purchase of 1,800,000 shares made by Krishna Yeshwant , and a net purchase of 76,000 shares made by Andrew D. Ashe .

In summary, during the past 3 months, insiders sold 1,514 shares of Verve Therapeutics Inc (VERV) in total and bought 76,000 shares, with a net purchase of 74,486 shares. During the past 18 months, 3,487 shares of Verve Therapeutics Inc (VERV) were sold and 1,876,000 shares were bought by its insiders, resulting in a net purchase of 1,872,513 shares.

Verve Therapeutics Inc (VERV)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Revolution Healthcare Acquisition Corp (REVHU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Revolution Healthcare Acquisition Corp (REVHU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Revolution Healthcare Acquisition Corp (REVHU)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of DA32 Life Science Tech Acquisition Corp (DALS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of DA32 Life Science Tech Acquisition Corp (DALS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

DA32 Life Science Tech Acquisition Corp (DALS)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Revolution Healthcare Acquisition Corp (REVH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Revolution Healthcare Acquisition Corp (REVH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Revolution Healthcare Acquisition Corp (REVH)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Robert Nelsen made 1 insider transaction in Prime Medicine Inc (PRME) with a net purchase of 3,200,000. Other recent insider transactions involving Prime Medicine Inc (PRME) include a net sale of 1,422,190 shares made by Gv 2019 Gp, L.l.c. , a net purchase of 3,200,000 shares made by Arch Venture Partners Xii, Llc , and a net purchase of 3,200,000 shares made by Arch Venture Partners X, Llc .

In summary, during the past 3 months, insiders sold 0 shares of Prime Medicine Inc (PRME) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,422,190 shares of Prime Medicine Inc (PRME) were sold and 9,600,000 shares were bought by its insiders, resulting in a net purchase of 8,177,810 shares.

Prime Medicine Inc (PRME)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Robert Nelsen made no insider transaction in Neumora Therapeutics Inc (NMRA). Other recent insider transactions involving Neumora Therapeutics Inc (NMRA) include a net purchase of 2,007,064 shares made by Kristina Burow , a net purchase of 507,064 shares made by Arch Venture Partners Xii, Llc , and a net purchase of 1,764,705 shares made by Amgen Inc .

In summary, during the past 3 months, insiders sold 0 shares of Neumora Therapeutics Inc (NMRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Neumora Therapeutics Inc (NMRA) were sold and 7,293,833 shares were bought by its insiders, resulting in a net purchase of 7,293,833 shares.

Neumora Therapeutics Inc (NMRA)'s detailed insider trading history can be found in Insider Trading Tracker table.